Deborah Dunsire, M.D. President & CEO of Millennium Pharmaceuticals,
Rings The NASDAQ Stock Market Opening Bell

Thursday, April 27, 2006
at NASDAQ's MarketSite
in New York City.

Millennium Pharmaceuticals

Millennium Pharmaceuticals (MLNM) President & CEO, presides over the opening bell .

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 4/27/2006 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Deborah Dunsire, M.D. President & CEO of Millennium Pharmaceuticals , rings the Opening Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.